drugset / Trial / NCT02837302
Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease
Phase 4
Unknown
1470 enrolled
Kyungpook National University Hospital
Samil Pharmaceutical Co., Ltd. · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Protein-calorie malnutrition is frequently observed in patients with advanced liver cirrhosis. There have been continued interests in potential benefits of long-term oral branched-chain amino acid supplement in improving severity of liver disease. However, there are limited evidences in literature. The aim of this study is to evaluate the efficacy of oral branched-chain amino acid in patients with advanced liver cirrhosis.
Timeline
- Start
- 2012-11
- Primary completion
- 2017-12
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Branched-chain Amino Acid | Other / unclassified | 12.45 g | Oral |